IndraLab

Statements

SJ1 inhibits KCNH2. 1 / 1

| 1

reach

"Although subsequent chemical optimization work improved the pharmacological properties of SJ1, including increased potency, reduced cytotoxicity, and elimination of hERG potassium channel activity 16, these analogs still exhibit ion channel binding."

21482722

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

SJ1 inhibits KCNH2. 1 / 1

INDRA sources:

Databases

Reading